Knowing more about the activation process has led researchers to be able to induce greater
vulnerability by cancer cells to an existing first - line treatment for cancers (mainly lung) driven by a receptor called EGFR.
Not exact matches
By reversing this change in
cancer cells, the drug restores
cancer cells»
vulnerability to drugs such as irinotecan.
A chemotherapy drug used to treat brain
cancer may increase
vulnerability to depression
by stopping new brain
cells from growing, according to a new King's College London study out today in Translational Psychiatry.
Interestingly, alterations in these un-druggable genes distinguish
cancer cells from normal
cells, conferring «synthetic lethal»
vulnerabilities that can be exploited
by novel targeted therapies.